GLP-1 Market
LLY $1149.85 ▼ -0.6% NVO $37.40 ▼ -1.3% PFE $28.12 ▼ -1.4% VKTX $30.51 ▼ -6.4% KLRA $11.03 ▼ -3.4% GPCR $28.98 ▼ -7.3% RHHBY $52.35 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Leucovorin Calcium

Company
National Cancer Institute (NCI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
56 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

56 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 2, 2026

Find a Clinical Trial Near Me

See recruiting studies for Leucovorin Calcium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03692429

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

    Not yet reported Celyad Oncology SA 49 participants Est. completion 2036-02-17 4 sites Stand-alone
    Other conditions: Unresectable Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT03832361

    Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

    Not yet reported Alessandro Santin 50 participants Est. completion 2028-10 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Recruiting NCT NCT04120701

    CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

    Not yet reported Centre Hospitalier Universitaire Dijon 1980 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Patients With Resected Stage II Colon Cancer
    View official trial listing →
  • Recruiting NCT NCT04205968

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

    Not yet reported SWOG Cancer Research Network 94 participants Est. completion 2027-08-01 536 sites Stand-alone
    Other conditions: Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8, Stage IIIA Small Intestinal Adenocarcinoma AJCC v8, Stage IIIB Small Intestinal Adenocarcinoma AJCC v8, Stage IV Small Intestinal Adenocarcinoma AJCC v8
    View official trial listing →
  • Recruiting NCT NCT04276857

    Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported University of Saskatchewan 27 participants Est. completion 2026-12-31 2 sites
    Other conditions: Locally Advanced Pancreatic Cancer, Irreversible Electroporation
    View official trial listing →
  • Recruiting NCT NCT04329494

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

    Not yet reported City of Hope Medical Center 49 participants Est. completion 2028-01-05 3 sites Stand-alone
    Other conditions: Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8, Malignant Uterine Neoplasm, Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Pathologic Stage IV Gastric Cancer AJCC v8, Peritoneal Carcinomatosis, Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8, Stage IV Appendix Carcinoma AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Appendix Carcinoma AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Appendix Carcinoma AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8, Stage IVC Appendix Carcinoma AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT04516681

    Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

    Not yet reported Fudan University 400 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Colorectal Cancer, Vitamin C, GLUT3
    View official trial listing →
  • Recruiting NCT NCT04847063

    Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-30 1 site Stand-alone
    Other conditions: Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer, Gastrointestinal Cancer, Appendiceal Cancer, Atypical Mesothelial Proliferation, Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04991948

    Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

    Not yet reported Celyad Oncology SA 34 participants Est. completion 2038-05-25 5 sites Stand-alone
    Other conditions: Unresectable Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05067283

    A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

    Not yet reported Merck Sharp & Dohme LLC 830 participants Est. completion 2030-02-25 75 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05424692

    Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2027-09-01 1 site
    Other conditions: Colon Cancer, Rectal Cancer, Chemotherapy Effect, PTC, Exon Mutation
    View official trial listing →
  • Recruiting NCT NCT05476432

    HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2026-10-01 3 sites Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05624138

    The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

    Not yet reported Tanta University 64 participants Est. completion 2025-06 1 site
    Other conditions: Neuropathy;Peripheral
    View official trial listing →
  • Recruiting NCT NCT05713994

    Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

    Ze-yang Ding, MD 300 participants Est. completion 2025-12-30 2 sites
    Other conditions: Hepatocellular Carcinoma Non-resectable
    View official trial listing →
  • Recruiting NCT NCT05719558

    A Study of ASP1002 in Adults for Treatment of Solid Tumors

    Not yet reported Astellas Pharma Global Development, Inc. 798 participants Est. completion 2030-05-31 15 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05727163

    FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

    Not yet reported Sun Yat-sen University 194 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT05825066

    Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

    Not yet reported Wake Forest University Health Sciences 64 participants Est. completion 2028-07 2 sites Stand-alone
    Other conditions: Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05859750

    A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

    Not yet reported Akeso 78 participants Est. completion 2025-12 7 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT06048484

    Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

    Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06121700

    Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

    Not yet reported Fudan University 55 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer, Oligometastatic Disease, Metastatic Cancer, Metastatic Gastric Cancer, Adenocarcinoma of the Stomach, Gastroesophageal Junction Adenocarcinoma, Metastatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06154538

    Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 170 participants Est. completion 2028-11-01 3 sites Stand-alone
    Other conditions: Locally Advanced Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06225843

    Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis

    Not yet reported Alethia Biotherapeutics 17 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06244225

    HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 38 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06278545

    Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

    Not yet reported Centre Hospitalier Universitaire Dijon 130 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Locally Advanced or Metastatic Small Bowel Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06402708

    Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

    Not yet reported Fudan University 172 participants Est. completion 2030-05-01 1 site Stand-alone
    Other conditions: Thymic Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06519422

    Tranexamic Acid for Anaemia Trial

    Not yet reported London School of Hygiene and Tropical Medicine 4000 participants Est. completion 2028-09 3 sites
    Other conditions: Anaemia
    View official trial listing →
  • Recruiting NCT NCT06519578

    Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

    Not yet reported RenJi Hospital 1115 participants Est. completion 2027-07-31 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06594419

    Healthy Baby Healthy Mother Toolkit

    Not yet reported Emory University 594 participants Est. completion 2026-04 2 sites
    Other conditions: Maternal Nutrition, Child Nutrition
    View official trial listing →
  • Recruiting NCT NCT06598007

    A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Crossignal Therapeutics, Inc. 78 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06637137

    Patient Blood Management in Patients Scheduled for Cardiac Surgery

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 464 participants Est. completion 2027-02-28 1 site
    Other conditions: Anemia, Anemia, Iron-Deficiency, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia (IDA), Cardiac Surgical Patients, Blood Loss, Surgical
    View official trial listing →
  • Recruiting NCT NCT06793917

    Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

    Not yet reported Fujian Cancer Hospital 269 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06820463

    A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    Not yet reported AbbVie 390 participants Est. completion 2028-04 75 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06835569

    A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    Not yet reported Alterome Therapeutics, Inc. 448 participants Est. completion 2029-08 12 sites Stand-alone
    Other conditions: Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC (Non-small Cell Lung Cancer), CRC (Colorectal Cancer), Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06856447

    The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

    Not yet reported toqa saad mohammed mohammed 22 participants Est. completion 2026-01-10 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06867822

    Trial of ProAgio in Advanced/Metastatic Colorectal Cancer

    Not yet reported University of Alabama at Birmingham 27 participants Est. completion 2028-07 1 site
    Other conditions: Advanced Colorectal Cancer, Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06890338

    A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

    Not yet reported AbbVie 140 participants Est. completion 2030-02 70 sites
    Other conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Neoadjuvant
    View official trial listing →
  • Recruiting NCT NCT06896188

    9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

    Not yet reported Anwaar Saeed 12 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06951503

    AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

    Not yet reported Akeso 560 participants Est. completion 2029-01-07 2 sites Stand-alone
    Other conditions: Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06976892

    Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

    Not yet reported Institute of Cancer Research, United Kingdom 33 participants Est. completion 2029-12 3 sites
    Other conditions: High Grade Serous Ovarian Cancer
    View official trial listing →
  • Recruiting NCT NCT07029282

    The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes

    Not yet reported Aga Khan University 3000 participants Est. completion 2027-12-31 1 site
    Other conditions: Newborn Health, Multiple Micronutrient Deficiencies During Pregnancy, Nutrition During Pregnancy, Adaptive Trial, Postnatal Growth, Neurodevelopment Outcome
    View official trial listing →
  • Recruiting NCT NCT07047560

    Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 46 participants Est. completion 2027-08-01 1 site Stand-alone
    Other conditions: Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07059299

    A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18 participants Est. completion 2027-08 4 sites Stand-alone
    Other conditions: Esophagogastric Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Resectable Esophagogastric Adenocarcinoma, Neoadjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07069712

    A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

    Not yet reported AstraZeneca 100 participants Est. completion 2029-07-16 70 sites Stand-alone
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07070076

    A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

    Not yet reported Li Qiang 286 participants Est. completion 2031-08-01 1 site
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07116057

    MOv19-BBz CAR T Cells in FRa+ Cancers

    Not yet reported University of Pennsylvania 10 participants Est. completion 2040-10 1 site
    Other conditions: Metastatic Non Small Cell Lung Cancer, Recurrent Lung Non-Small Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07277270

    A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

    Not yet reported GlaxoSmithKline 83 participants Est. completion 2030-05-01 22 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07283367

    A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.

    Not yet reported, Not yet reported Hansoh BioMedical R&D Company 502 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: CRC
    View official trial listing →
  • Recruiting NCT NCT07328087

    COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

    Not yet reported Biogenea Pharmaceuticals Ltd. 12 participants Est. completion 2031-12-02 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV
    View official trial listing →
  • Recruiting NCT NCT07337434

    To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

    Not yet reported Syeda Sana Zaman 106 participants Est. completion 2026-06-25 1 site
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Recruiting NCT NCT07337460

    Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

    Not yet reported Northern Jiangsu People's Hospital 30 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07474727

    A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

    Not yet reported Multitude Therapeutics Inc. 180 participants Est. completion 2028-02-28 19 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07543744

    A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

    Not yet reported R-Pharm 180 participants Est. completion 2028-08 26 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07630506

    Folinic Acid as a Treatment for Autism Spectrum Disorder in Children

    Not yet reported KK Women's and Children's Hospital 184 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT07673887

    A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

    Not yet reported Astellas Pharma Global Development, Inc. 570 participants Est. completion 2031-02-28 3 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07790510

    HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Haisco Pharmaceutical Group Co., Ltd. 180 participants Est. completion 2030-09-30 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07809893

    Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00000395

    Antifolate Effectiveness in Arthritis

    Not yet reported University of Alabama at Birmingham 40 participants Est. completion 2002-08 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Adjuvant Arthritis
    View official trial listing →
  • Completed NCT NCT00000703

    Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 1990-03 14 sites
    Other conditions: Lymphoma, Non-Hodgkin, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000794

    Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 1998-04 16 sites
    Other conditions: Toxoplasmosis, Cerebral, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000973

    A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 26 participants Est. completion 1995-03 2 sites
    Other conditions: Toxoplasmosis, Cerebral, HIV Infections
    View official trial listing →
  • Completed NCT NCT00000998

    A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 1989-04 1 site
    Other conditions: Pneumonia, Pneumocystis Carinii, HIV Infections
    View official trial listing →
  • Completed NCT NCT00001239

    Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2001-01 1 site
    Other conditions: Breast Cancer, Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00002002

    A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome

    Not yet reported Lederle Laboratories 1 site
    Other conditions: Pneumonia, Pneumocystis Carinii, HIV Infections
    View official trial listing →
  • Completed NCT NCT00002489

    Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2002-06 1 site
    Other conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00002494

    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

    Not yet reported Alliance for Clinical Trials in Oncology 134 participants Est. completion 2006-01 23 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00002514

    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission

    Not yet reported Eastern Cooperative Oncology Group 1929 participants 94 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Terminated NCT NCT00002525

    Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed

    Not yet reported ECOG-ACRIN Cancer Research Group 859 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00002532

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

    Not yet reported Hannover Medical School 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002650

    High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed

    Not yet reported Eastern Cooperative Oncology Group 80 participants Est. completion 2009-05-01 8 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00002665

    SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

    Not yet reported SWOG Cancer Research Network 50 participants Est. completion 2003-12 83 sites
    Other conditions: Leukemia, Neutropenia, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00002704

    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 156 participants 70 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002835

    Combination Chemotherapy in Treating Patients With Lymphoma

    Not yet reported M.D. Anderson Cancer Center 116 participants Est. completion 2004-02-04 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003215

    Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

    Not yet reported Swiss Cancer Institute 400 participants Est. completion 2004-03 12 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00003273

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

    Not yet reported NYU Langone Health 19 sites
    Other conditions: Brain and Central Nervous System Tumors, Neuroblastoma, Retinoblastoma, Sarcoma
    View official trial listing →
  • Completed NCT NCT00003925

    Combination Chemotherapy In Treating Patients With Advanced Cancer

    Not yet reported Barbara Ann Karmanos Cancer Institute 36 participants Est. completion 2007-08 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00004734

    Vitamin Therapy for Prevention of Stroke

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) Est. completion 2004-02 1 site
    Cardiovascular disease Other conditions: Cerebral Infarction
    View official trial listing →
  • Completed NCT NCT00004860

    Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

    Not yet reported Eastern Cooperative Oncology Group 51 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00004885

    Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 430 participants 57 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00005036

    Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 560 participants 1 site Stand-alone
    Other conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT00005944

    Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

    Not yet reported UNICANCER Est. completion 2003-10-01 18 sites
    Other conditions: Colorectal Cancer, Metastatic Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00005977

    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

    Not yet reported Children's Oncology Group 83 participants Est. completion 2006-09 119 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00016133

    Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

    Not yet reported, Not yet reported Intracel Est. completion 2004-08 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00018460

    Anticoagulation, Vitamins, and Endothelial Function

    Not yet reported US Department of Veterans Affairs Est. completion 2002-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00023998

    Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

    Not yet reported National Cancer Institute (NCI) 80 participants Est. completion 2007-05 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00025142

    Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

    Not yet reported Stanford University Est. completion 2006-11 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00034463

    ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer

    Not yet reported Eli Lilly and Company 1 site
    Other conditions: Metastases, Cancer
    View official trial listing →
  • Terminated NCT NCT00036517

    Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

    Not yet reported, Not yet reported PhytoCeutica 30 participants Est. completion 2003-03 3 sites
    Other conditions: Colorectal Neoplasms, Diarrhea
    View official trial listing →
  • Completed NCT NCT00039130

    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia

    Not yet reported Alliance for Clinical Trials in Oncology 105 participants Est. completion 2014-10 31 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00039611

    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2007-10 19 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00043121

    Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery

    Not yet reported National Cancer Institute (NCI) 50 participants 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00044785

    Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors

    Not yet reported Wellstat Therapeutics 24 participants Est. completion 2004-03 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00045539

    Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

    Not yet reported New Approaches to Brain Tumor Therapy Consortium Est. completion 2006-01 9 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00061815

    Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

    Not yet reported Eli Lilly and Company 102 participants Est. completion 2005-11 39 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00066274

    Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported UNICANCER Est. completion 2007-04-01 17 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00075595

    Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 15 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00077233

    FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

    Not yet reported Alliance for Clinical Trials in Oncology 238 participants Est. completion 2010-06 77 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00081536

    Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

    Not yet reported, Not yet reported Aronex Pharmaceuticals 105 participants
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00082797

    High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

    Not yet reported Eastern Cooperative Oncology Group 36 participants 65 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00098319

    Oral Cleft Prevention Trial in Brazil

    Not yet reported NICHD Global Network for Women's and Children's Health 2200 participants Est. completion 2007-04 3 sites
    Other conditions: Cleft Lip, Cleft Palate
    View official trial listing →
  • Completed NCT NCT00098839

    Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

    Not yet reported, Not yet reported Children's Oncology Group 134 participants Est. completion 2011-04 46 sites Stand-alone
    Other conditions: Recurrent Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00109837

    S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported SWOG Cancer Research Network 79 participants Est. completion 2014-11 78 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00114400

    BVAIT: B-Vitamin Atherosclerosis Intervention Trial

    Not yet reported, Not yet reported National Institute on Aging (NIA) 506 participants Est. completion 2007-02 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00133744

    Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality

    Not yet reported Centers for Disease Control and Prevention 18962 participants Est. completion 2010-12 5 sites
    Other conditions: Perinatal Mortality, Stillbirth, Neonatal Mortality
    View official trial listing →
  • Status unknown NCT NCT00155935

    The Development of Human Immunologic Assays Specific to Folate Receptor Antigen

    Not yet reported National Taiwan University Hospital 50 participants Est. completion 2008-12 1 site
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00190515

    A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

    Not yet reported Haruhiko Fukuda 1101 participants Est. completion 2011-11 48 sites Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00192075

    A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer

    Not yet reported Eli Lilly and Company 84 participants Est. completion 2007-11 15 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00197678

    Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women

    Not yet reported Harvard School of Public Health (HSPH) 1141 participants Est. completion 2005-07 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00197704

    Nutrition, Immunology and Epidemiology of Tuberculosis

    Not yet reported Harvard School of Public Health (HSPH) 876 participants Est. completion 2004-05 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00197730

    Trial of Vitamins Among Children of HIV-infected Women

    Not yet reported Harvard School of Public Health (HSPH) 2387 participants Est. completion 2008-05 1 site
    Other conditions: HIV Infections, Pregnancy Complications
    View official trial listing →
  • Completed NCT NCT00200200

    Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 73 participants Est. completion 2025-03-13 5 sites Stand-alone
    Other conditions: Hepatic Metastases, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00214682

    Beyond Ageing Project: A Study for the Prevention of Depression

    Not yet reported Australian National University 909 participants Est. completion 2011-01 1 site
    Other conditions: Depression, Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00226356

    Natural Supplements for Unipolar Depression

    Not yet reported Cambridge Health Alliance 20 participants Est. completion 2008-09-17 1 site
    Other conditions: Unipolar Depression
    View official trial listing →
  • Completed NCT NCT00262808

    GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

    Not yet reported University of Rochester 50 participants Est. completion 2006-09 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00266487

    The Norwegian Vitamin Trial (NORVIT)

    Not yet reported University of Tromso 3750 participants Est. completion 2004-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00268398

    Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 284 participants 32 sites Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer, Chemotherapy
    View official trial listing →
  • Terminated NCT NCT00275106

    Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma

    Not yet reported Children's Cancer and Leukaemia Group 600 participants Est. completion 2012-08 22 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00280618

    Oxaliplatin in Unresectable Hepatocellular Carcinoma

    Not yet reported Sanofi
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Terminated NCT NCT00298272

    Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

    Not yet reported Biogen 54 participants Est. completion 2011-07 18 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00299130

    A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis

    Not yet reported Genentech, Inc. 511 participants Est. completion 2013-07
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00303758

    Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

    Not yet reported Federation Francophone de Cancerologie Digestive 202 participants Est. completion 2012-03 46 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00308269

    Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)

    Not yet reported Endocyte 32 participants Est. completion 2008-07 2 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT00320294

    ILF With/Without Cisplatin for Advanced Gastric Cancer

    Not yet reported Gachon University Gil Medical Center 86 participants Est. completion 2007-03 1 site
    Other conditions: Stomach Neoplasm
    View official trial listing →
  • Completed NCT NCT00323960

    Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis

    Not yet reported Istituto Giannina Gaslini 139 participants Est. completion 2015-11-29 1 site
    Other conditions: Juvenile Dermatomyositis
    View official trial listing →
  • Completed NCT NCT00336024

    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

    Not yet reported Children's Oncology Group 91 participants Est. completion 2025-09-30 145 sites Stand-alone
    Other conditions: Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    View official trial listing →
  • Completed NCT NCT00381706

    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 245 participants Est. completion 2014-10-15 227 sites Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00382720

    Docetaxel and Oxaliplatin in Gastric Cancer

    Not yet reported Sanofi 275 participants Est. completion 2010-04 12 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Terminated NCT NCT00385021

    ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

    Not yet reported Southwestern Regional Medical Center 20 participants Est. completion 2007-09 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00390416

    Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

    Not yet reported Memorial Sloan Kettering Cancer Center 48 participants Est. completion 2012-01 5 sites Stand-alone
    Other conditions: Stomach Neoplasms, Esophageal Neoplasms
    View official trial listing →
  • Completed NCT NCT00393822

    A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

    Not yet reported, Not yet reported Amgen 100 participants Est. completion 2014-03
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT00408551

    Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

    Not yet reported Goshen Health System 20 participants 1 site Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00421668

    A Trial of Zinc and Micronutrients in Tanzanian Children

    Not yet reported Harvard School of Public Health (HSPH) 2400 participants Est. completion 2012-10 1 site
    Other conditions: Diarrheal Illnesses, Respiratory Illness, Growth Faltering
    View official trial listing →
  • Completed NCT NCT00450801

    R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma

    Not yet reported University of Miami 22 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00467363

    The Effects of Aspirin in Gestation and Reproduction

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1228 participants Est. completion 2012-07 4 sites
    Other conditions: Birth, Spontaneous Abortion
    View official trial listing →
  • Completed NCT NCT00470158

    Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes

    Not yet reported Johns Hopkins Bloomberg School of Public Health 1000 participants Est. completion 2008-02 1 site
    Other conditions: Anemia, Diarrhea, Iron
    View official trial listing →
  • Completed NCT NCT00481871

    Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

    Not yet reported, Not yet reported Acrotech Biopharma Inc. 119 participants Est. completion 2011-08 15 sites
    Other conditions: Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00502567

    A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

    Not yet reported AstraZeneca 104 participants Est. completion 2011-06 3 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT00507091

    Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

    Not yet reported Genzyme, a Sanofi Company 24 participants Est. completion 2008-06 3 sites Stand-alone
    Other conditions: Metastatic, Colorectal, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00514020

    Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 33 participants Est. completion 2011-02 5 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00515216

    Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

    Not yet reported Vanderbilt University 26 participants Est. completion 2013-11 4 sites Stand-alone
    Other conditions: Stomach Neoplasms, Esophageal Neoplasms
    View official trial listing →
  • Terminated NCT NCT00541112

    Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

    Not yet reported UNICANCER 19 participants Est. completion 2010-01-29 10 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT00550992

    Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

    Not yet reported Dutch Childhood Oncology Group 445 participants 13 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00587873

    Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

    Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00588536

    Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

    Not yet reported Memorial Sloan Kettering Cancer Center 5 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Langerhans Cell Histiocytosis
    View official trial listing →
  • Completed NCT NCT00606502

    Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment

    Not yet reported Spectrum Pharmaceuticals, Inc 201 participants Est. completion 2010-06-24 47 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00623857

    Micronutrients and Child Health Study

    Not yet reported Wageningen University 612 participants Est. completion 2009-03 1 site
    Other conditions: Malaria
    View official trial listing →
  • Completed NCT NCT00631410

    Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

    Not yet reported Pfizer 12 participants Est. completion 2010-03 3 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Terminated NCT NCT00634322

    High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

    Not yet reported BTG International Inc. 7 participants Est. completion 2009-04
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00668863

    Study Of Sunitinib With FOLFIRI In Colorectal Cancer

    Not yet reported Pfizer 71 participants Est. completion 2010-09 10 sites Stand-alone
    Other conditions: Unresectable or Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00677287

    Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

    Not yet reported, Not yet reported Tokyo University 14 participants Est. completion 2009-03 1 site
    Other conditions: Colorectal Cancer, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT00677612

    Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

    Not yet reported, Not yet reported Tokyo University 14 participants Est. completion 2009-03 1 site
    Other conditions: Colorectal Cancer, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00709267

    Bioavailability Study of Folic Acid in Healthy Women

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 12 participants Est. completion 2004-12
    Other conditions: Healthy, Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT00720512

    Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab

    Not yet reported Gruppo Oncologico del Nord-Ovest 184 participants Est. completion 2014-03 21 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00722553

    Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

    Not yet reported Acrotech Biopharma Inc. 30 participants Est. completion 2011-09 19 sites
    Other conditions: Carcinoma, Transitional Cell, Bladder Cancer, Bladder Neoplasm
    View official trial listing →
  • Completed NCT NCT00726713

    Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

    Not yet reported Pamlab, Inc. 214 participants Est. completion 2011-06 6 sites
    Other conditions: Type 2 Diabetic Peripheral Neuropathy (DPN)
    View official trial listing →
  • Completed NCT NCT00728273

    Efficacy of Multiple Micronutrient Fortified Biscuits and Deworming in Vietnamese School Children

    Not yet reported Neys-van Hoogstraten Foundation, The Netherlands 510 participants Est. completion 2007-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00779311

    A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

    Not yet reported Accelerated Community Oncology Research Network 8 participants Est. completion 2011-03 3 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00807807

    Evaluating the Effects of Folic Acid Supplementation in Older Adults: The Folic Acid Supplementation Trial (The FAST Study)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 133 participants Est. completion 1996-09
    Other conditions: Heart Diseases
    View official trial listing →
  • Completed NCT NCT00831181

    Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

    Not yet reported Beth Israel Medical Center 27 participants Est. completion 2009-11 2 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00849615

    Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

    Not yet reported Krankenhaus Nordwest 252 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT00860470

    Antenatal Micronutrient Supplementation and Infant Survival

    Not yet reported Johns Hopkins Bloomberg School of Public Health 44567 participants Est. completion 2012-09 2 sites
    Other conditions: Infant Mortality, Preterm Birth, Low Birth Weight, Neonatal Mortality, Perinatal Mortality
    View official trial listing →
  • Completed NCT NCT00865709

    Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

    Not yet reported Bayer 198 participants Est. completion 2012-02 116 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00881504

    A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

    Not yet reported Georgetown University 9 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT00898404

    Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate

    Children's Oncology Group 150 participants Est. completion 2016-05 1 site
    Other conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00940303

    OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 97 participants Est. completion 2014-02 17 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00957905

    Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

    Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2014-08 10 sites Stand-alone
    Other conditions: Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor, Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage III Testicular Cancer, Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00959647

    A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

    Not yet reported Genentech, Inc. 19 participants Est. completion 2014-01-09 10 sites Stand-alone
    Other conditions: Ovarian Cancer, Basal Cell Carcinoma, Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00973609

    Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

    Not yet reported AIO-Studien-gGmbH 853 participants Est. completion 2015-08 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00975364

    Folate Gene Polymorphisms and Cellular Folate Speciation Pilot Study

    Quadram Institute Bioscience 100 participants Est. completion 2010-12 1 site
    Other conditions: Single Nucleotide Polymorphism
    View official trial listing →
  • Completed NCT NCT01001559

    Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

    Pamlab, Inc. 242 participants Est. completion 2011-06 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT01039181

    Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

    Not yet reported National Science and Technology Development Agency, Thailand 28 participants Est. completion 2012-10 1 site
    Other conditions: Advanced Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT01050556

    Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic

    Not yet reported Columbia University 600 participants Est. completion 2011-06 1 site
    Other conditions: High Blood Arsenic Due to Chronic Arsenic Exposure
    View official trial listing →
  • Completed NCT NCT01057589

    A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

    Not yet reported Eli Lilly and Company 66 participants Est. completion 2012-10 13 sites
    Other conditions: Head and Neck Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01074996

    Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers

    Not yet reported The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 92 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01095211

    B-vitamins Treatment for Improvement of Cognitive Function

    Not yet reported Universität des Saarlandes 79 participants Est. completion 2009-12 1 site
    Other conditions: Cognitive Function, Metabolic Improvements
    View official trial listing →
  • Completed NCT NCT01105351

    Effect of Folic Acid on Primary Folate Forms in Relation to MTHFR

    Not yet reported Universität des Saarlandes 75 participants Est. completion 2013-12 1 site
    Other conditions: the Effect of MTHFR C677T on Folate Metabolism
    View official trial listing →
  • Completed NCT NCT01118624

    Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

    Not yet reported Acrotech Biopharma Inc. 22 participants Est. completion 2012-07 14 sites
    Other conditions: Breast Cancer, Breast Tumors, Neoplasms, Breast, Cancer of the Breast, Human Mammary Carcinoma
    View official trial listing →
  • Completed NCT NCT01163396

    First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 57 participants Est. completion 2010-04 Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01204307

    Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation

    Not yet reported Chang Gung Memorial Hospital 101 participants Est. completion 2015-06 4 sites
    Other conditions: Advanced Non-Squamous Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01205022

    Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01206530

    FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 50 participants Est. completion 2017-09 1 site
    Other conditions: Rectal Cancer, Colon Cancer, Metastasis, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01226719

    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

    Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2014-03 15 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01227707

    A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.

    Not yet reported Hoffmann-La Roche 43 participants Est. completion 2010-08 9 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01229111

    Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

    Not yet reported National Cancer Institute (NCI) 14 participants Est. completion 2014-03 7 sites Stand-alone
    Other conditions: Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Unresectable Adult Primary Liver Cancer, Periampullary Adenocarcinoma, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    View official trial listing →
  • Completed NCT NCT01230983

    Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

    Not yet reported Children's Oncology Group 573 participants Est. completion 2004-10
    Other conditions: Cardiac Toxicity, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01235767

    Animal Source Food Supplement and Pregnancy in Vietnam

    Not yet reported UCSF Benioff Children's Hospital Oakland 291 participants Est. completion 2016-05 1 site
    Other conditions: Low Birth Weight, Preterm Birth
    View official trial listing →
  • Status unknown NCT NCT01238926

    Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease

    Not yet reported New York Institute of Technology 40 participants Est. completion 2010-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01238939

    Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

    Not yet reported Nippon Kayaku Co., Ltd. 35 participants Est. completion 2014-03 1 site
    Other conditions: Advanced Solid Tumors, Metastatic Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01239693

    Supplementing Maternal and Infant Diet With High-energy, Micronutrient Fortified Lipid-based Nutrient Supplements (LNS)

    Not yet reported Tampere University 1391 participants Est. completion 2027-03-31 1 site
    Other conditions: Infant Malnutrition, Malnutrition in Pregnancy
    View official trial listing →
  • Status unknown NCT NCT01244347

    Folic Acid Dosage and Malformations Reduction

    Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 5000 participants Est. completion 2016-09 34 sites
    Other conditions: Congenital Malformations
    View official trial listing →
  • Completed NCT NCT01246960

    A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

    Not yet reported Eli Lilly and Company 168 participants Est. completion 2014-05 58 sites Stand-alone
    Other conditions: Stomach Cancer, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01256398

    Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2021-11-15 101 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    View official trial listing →
  • Terminated NCT NCT01258634

    A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

    Not yet reported University of Chicago 2 participants Est. completion 2011-11 1 site
    Obstructive sleep apnea Other conditions: Lung Metastases
    View official trial listing →
  • Terminated NCT NCT01307956

    Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

    Not yet reported University of Nebraska 11 participants Est. completion 2015-12-23 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Adenocarcinoma, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01312857

    Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 75 participants Est. completion 2024-07-15 8 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01315990

    FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema

    Not yet reported Dr. Carl Schimanski 165 participants Est. completion 2018-03 1 site
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Terminated NCT NCT01320683

    Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01355159

    High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention

    Not yet reported Ottawa Hospital Research Institute 2464 participants Est. completion 2016-09 72 sites
    Other conditions: Pregnancy Complications, Preeclampsia
    View official trial listing →
  • Terminated NCT NCT01359007

    FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

    Not yet reported University of Oklahoma 5 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Adenocarcinoma of Pancreas
    View official trial listing →
  • Completed NCT NCT01360528

    Serum Folic Acid Levels in Preterm Infants

    Mehmet Yekta 100 participants Est. completion 2011-10 1 site
    Other conditions: Very Low Birth Weight Baby
    View official trial listing →
  • Completed NCT NCT01362361

    TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 54 participants Est. completion 2016-12 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01365975

    Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study

    National Cancer Institute (NCI) 1382 participants Est. completion 2020-03-02 1 site
    Other conditions: Pediatric Leukemia, Other Pediatric Cancers
    View official trial listing →
  • Completed NCT NCT01371357

    The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers

    Not yet reported Center for Health Sciences, Serbia 40 participants Est. completion 2011-12 1 site
    Other conditions: Hyperhomocysteinemia
    View official trial listing →
  • Terminated NCT NCT01375816

    Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 55 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01460589

    Early Commencement of Adjuvant Chemotherapy for Colon Cancer

    Not yet reported Kyungpook National University Hospital 303 participants Est. completion 2026-12-28 2 sites Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT01467921

    Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

    Not yet reported Samsung Medical Center 68 participants 1 site Stand-alone
    Other conditions: Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01472601

    A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile

    Samsung Medical Center 2660 participants Est. completion 2020-04 1 site
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT01482962

    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

    Not yet reported Millennium Pharmaceuticals, Inc. 271 participants Est. completion 2017-12-18 151 sites
    Other conditions: Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01484756

    Combined Vitamins and Minerals Decrease Incidence of Upper Respiratory Tract Infections in Older Persons

    Not yet reported Trisakti University 270 participants Est. completion 2009-03 1 site
    Other conditions: Upper Respiratory Tract Infection
    View official trial listing →
  • Completed NCT NCT01488552

    Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Pancreatic Cancer Research Team 60 participants Est. completion 2016-08 5 sites Stand-alone
    Other conditions: Stage IV Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01490866

    A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

    Not yet reported SCRI Development Innovations, LLC 70 participants Est. completion 2015-07 12 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01490944

    Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls

    Not yet reported Indian Council of Medical Research 360 participants Est. completion 2013-01 1 site
    Other conditions: Anaemia
    View official trial listing →
  • Completed NCT NCT01503372

    FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer

    Not yet reported Charite University, Berlin, Germany 75 participants Est. completion 2017-12-14 1 site Stand-alone
    Other conditions: Advanced Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01517139

    Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers

    National Cancer Institute (NCI) 278 participants Est. completion 2013-08-27 1 site
    Other conditions: Methylation, Body Composition, Physical Activity, Puberty
    View official trial listing →
  • Completed NCT NCT01524094

    Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

    Not yet reported Uppsala University 49 participants Est. completion 2012-01 1 site
    Other conditions: Colorectal Peritoneal Carcinomatosis
    View official trial listing →
  • Status unknown NCT NCT01533324

    S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

    Not yet reported Second Military Medical University 32 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Carcinoma, Liver Diseases, Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01535053

    Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

    Not yet reported GOG Foundation 57 participants Est. completion 2020-07-17 289 sites
    Other conditions: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor, FIGO Stage III Gestational Trophoblastic Tumor, Hydatidiform Mole
    View official trial listing →
  • Status unknown NCT NCT01538316

    Prostate Cancer Prevention Trial With Quercetin and Genistein

    Not yet reported University of Hohenheim 60 participants Est. completion 2014-04 2 sites
    Other conditions: Primary Prevention of Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01570088

    Bioavailability of Folic Acid Fortified Bread

    Not yet reported University of British Columbia 45 participants Est. completion 2012-12 1 site
    Other conditions: Red Blood Cell Folate
    View official trial listing →
  • Completed NCT NCT01590719

    A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer

    Not yet reported Hoffmann-La Roche 123 participants Est. completion 2014-10 36 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Withdrawn NCT NCT01605344

    Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2014-07 1 site
    Other conditions: Advanced Adenocarcinoma of the Colon or Rectum
    View official trial listing →
  • Completed NCT NCT01609556

    First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors

    Not yet reported ImmunoGen, Inc. 206 participants Est. completion 2018-03-19 12 sites
    Other conditions: Tumors
    View official trial listing →
  • Completed NCT NCT01660711

    A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

    Not yet reported Endeavor Health 22 participants Est. completion 2018-08-22 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01662869

    A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer

    Not yet reported Hoffmann-La Roche 564 participants Est. completion 2015-12 125 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01689636

    Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

    Not yet reported Endocyte 8 participants Est. completion 2002-07 1 site
    Other conditions: Ovarian Cancer, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01689714

    Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

    Not yet reported Endocyte 16 participants Est. completion 2005-08
    Other conditions: Ovarian Carcinoma, Recurrent Endometrial Carcinoma
    View official trial listing →
  • Completed NCT NCT01711359

    A Study in Participants With Moderate to Severe Rheumatoid Arthritis

    Not yet reported Eli Lilly and Company 588 participants Est. completion 2015-08 154 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01715233

    Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Metastatic Esophageal Cancer, Gastroesophageal Cancer, Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01736904

    wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

    Not yet reported Fudan University 100 participants Est. completion 2015-12 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01740648

    Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 19 participants Est. completion 2021-09-29 4 sites Stand-alone
    Other conditions: Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer, Stage IIC Rectal Cancer, Stage IIIA Rectal Cancer, Stage IIIB Rectal Cancer, Stage IIIC Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT01760694

    Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

    Not yet reported Southwestern Regional Medical Center 6 participants Est. completion 2014-07 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01775111

    Influence of Strength Training and Protein Supplementation on Fitness of Institutionalized Elderly

    Not yet reported University of Vienna 120 participants 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT01788189

    Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas

    Not yet reported, Not yet reported University Hospital, Essen 37 participants Est. completion 2020-02-20 1 site Stand-alone
    Other conditions: B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01814501

    Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

    Not yet reported John Hays 16 participants Est. completion 2018-08-06 2 sites Stand-alone
    Other conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT01818414

    Same-day Dilapan-S With Adjunctive Misoprostol

    Not yet reported University of Pittsburgh 29 participants Est. completion 2014-04 2 sites
    Other conditions: Therapeutic Abortion
    View official trial listing →
  • Completed NCT NCT01827553

    Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

    Not yet reported University of Erlangen-Nürnberg Medical School 830 participants Est. completion 2023-11-08 23 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01828710

    Myo-inositol on Human Semen Parameters

    Not yet reported AGUNCO Obstetrics and Gynecology Centre 62 participants Est. completion 2012-11 1 site
    Other conditions: Asthenozoospermia, Oligospermia
    View official trial listing →
  • Status unknown NCT NCT01832948

    Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

    Not yet reported Zhejiang Cancer Hospital 30 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01836575

    Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2

    Not yet reported Instituto Nacional de Cancer, Brazil 228 participants Est. completion 2012-12 9 sites
    Other conditions: Non Small Cell Lung Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT01854372

    Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.

    Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2013-11 Stand-alone
    Other conditions: Newly Diagnosed Diffuse Large B-Cell Lymphoma, Intermediate (Burkitt-Like) Lymphoma
    View official trial listing →
  • Terminated NCT NCT01858662

    Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 4 participants Est. completion 2015-11 7 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01878916

    Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs

    Istanbul University Est. completion 2004-06 1 site
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT01882868

    A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

    Not yet reported Sanofi 62 participants Est. completion 2015-08 19 sites
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01896531

    A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

    Not yet reported Genentech, Inc. 153 participants Est. completion 2021-01-26 34 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01905150

    Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

    Not yet reported Bruckner Oncology 34 participants Est. completion 2020-01 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01953419

    Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy

    Not yet reported Sun Yat-sen University 34 participants Est. completion 2014-06 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Withdrawn NCT NCT01953536

    Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

    Not yet reported Endocyte Est. completion 2016-11
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01959139

    S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

    Not yet reported, Not yet reported SWOG Cancer Research Network 126 participants Est. completion 2023-11-09 154 sites Stand-alone
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01959672

    Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

    Not yet reported University of Nebraska 11 participants Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage I Pancreatic Cancer, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01964534

    Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 114 participants Est. completion 2017-07 15 sites Stand-alone
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02016586

    Breastfeeding Intervention Study

    Not yet reported Abbott Nutrition 228 participants Est. completion 2015-05 18 sites
    Other conditions: Breast Feeding
    View official trial listing →
  • Completed NCT NCT02022033

    BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

    Not yet reported Brown University 25 participants Est. completion 2022-03-17 2 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02028806

    mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

    Not yet reported Yuhong Li 40 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT02071069

    Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

    Not yet reported Tianshu Liu 54 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Incurable Colorectal Cancer, RAS-wild-type
    View official trial listing →
  • Status unknown NCT NCT02102789

    A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis

    Not yet reported Yuhong Li 142 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02124642

    Folic Acid Supplementation in Pregnant Women: Dose Response

    Not yet reported University of Georgia 51 participants Est. completion 2017-12 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT02129257

    Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

    Not yet reported Hellenic Cooperative Oncology Group 73 participants Est. completion 2017-09-25 18 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02138617

    Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 100 participants Est. completion 2024-08-01 7 sites Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Terminated NCT NCT02141295

    A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 197 participants Est. completion 2017-02-01 39 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02151851

    A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis

    Not yet reported UCB Pharma SA, Belgium 430 participants Est. completion 2016-06 30 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02218931

    ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes

    Not yet reported Queen Mary University of London 3442 participants Est. completion 2017-04-30 1 site
    Other conditions: Pre-eclampsia, Obesity, Raised Lipids, High Blood Pressure, Insulin Resistance, Gestational Diabetes, Small for Gestational Age, Stillbirth
    View official trial listing →
  • Completed NCT NCT02231723

    A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

    Not yet reported Sumitomo Pharma America, Inc. 139 participants Est. completion 2020-06 12 sites Stand-alone
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02238704

    Cornell University-Micronutrient Initiative Calcium Supplementation Study

    Not yet reported Cornell University 1032 participants Est. completion 2016-06 16 sites
    Other conditions: Preeclampsia
    View official trial listing →
  • Completed NCT NCT02270788

    Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 10 participants Est. completion 2016-10-17 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02284529

    Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

    Not yet reported Sinphar Pharmaceutical Co., Ltd 20 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Stage-Ⅱ Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02344888

    Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOS

    Not yet reported Mahmoud Thabet 300 participants Est. completion 2019-01 2 sites
    Other conditions: Infertility, Polycystic Ovarian Syndrome
    View official trial listing →
  • Terminated NCT NCT02345460

    Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study

    Not yet reported Case Comprehensive Cancer Center 1 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Neoplasm, Resectable Pancreatic Cancer, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer, Undifferentiated Pancreatic Carcinoma
    View official trial listing →
  • Completed NCT NCT02360345

    Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly

    Not yet reported Royal Marsden NHS Foundation Trust 111 participants Est. completion 2021-03 1 site
    Other conditions: Solid Tumours
    View official trial listing →
  • Suspended NCT NCT02366819

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

    Not yet reported University of Chicago 36 participants Est. completion 2026-06-08 3 sites Stand-alone
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Stage IIB Gastric Cancer, Stage IIIA Esophageal Adenocarcinoma, Stage IIIA Gastric Cancer, Stage IIIB Esophageal Adenocarcinoma, Stage IIIB Gastric Cancer, Stage IIIC Esophageal Adenocarcinoma, Stage IIIC Gastric Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02394834

    An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

    Takeda 757 participants Est. completion 2027-09-30 151 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT02420509

    Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

    University of California, San Diego 2 participants Est. completion 2019-04-02 1 site
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT02420717

    Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2021-01-20 1 site Stand-alone
    Other conditions: Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory Ph-Like Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT02422927

    Nutraceutical Combination in Patients With Low-grade Systemic Inflammation

    Not yet reported University Of Perugia 100 participants Est. completion 2015-02
    Other conditions: Atherosclerosis, Inflammation, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02486497

    Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining

    Not yet reported Seoul National University Hospital 40 participants Est. completion 2017-05 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT02506842

    Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

    Not yet reported Fudan University 300 participants Est. completion 2019-06 7 sites Stand-alone
    Other conditions: Stage ⅠA Pancreatic Cancer, Stage ⅠB Pancreatic Cancer, Stage ⅡA Pancreatic Cancer, Stage ⅡB Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT02508077

    FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2017-09-13 4 sites Stand-alone
    Other conditions: Recurrent Colorectal Carcinoma, Stage IVA Colorectal Cancer, Stage IVB Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02511054

    Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 57 participants Est. completion 2017-06-01 1 site
    Other conditions: Malaria
    View official trial listing →
  • Status unknown NCT NCT02515734

    A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

    Not yet reported Japan Clinical Cancer Research Organization 360 participants Est. completion 2020-06 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02539537

    A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

    Not yet reported UNICANCER 171 participants Est. completion 2023-09-25 45 sites Stand-alone
    Other conditions: Pancreatic Cancer, Carcinoma
    View official trial listing →
  • Completed NCT NCT02545504

    Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Gilead Sciences 432 participants Est. completion 2019-05-15 134 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02578732

    FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

    Not yet reported Brown University 28 participants Est. completion 2022-03-16 1 site Stand-alone
    Other conditions: Locally Advanced Pancreatic Cancer, Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02586181

    Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People (KnoVIB)

    Not yet reported Universität des Saarlandes 93 participants Est. completion 2011-07 1 site
    Other conditions: Nutritional Supplement Toxicity
    View official trial listing →
  • Completed NCT NCT02593136

    Home Fortification of Complementary Foods in Bihar India

    Not yet reported Emory University 11861 participants Est. completion 2016-03 1 site
    Other conditions: Anemia, Malnutrition
    View official trial listing →
  • Completed NCT NCT02610881

    Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children

    Not yet reported Emory University 110 participants Est. completion 2016-04 1 site
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT02645409

    Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

    Not yet reported Chandru Sundaram 14 participants Est. completion 2019-04-02 2 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02648425

    Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

    Not yet reported ASLAN Pharmaceuticals 31 participants Est. completion 2017-09-15 3 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Terminated NCT NCT02701517

    Cyclosporine Plus Methotrexate or Alemtuzumab

    Not yet reported Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 72 participants Est. completion 2009-11 5 sites
    Other conditions: Unrecognized Condition: Mature B or T-cell Neoplasm
    View official trial listing →
  • Completed NCT NCT02715531

    A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

    Not yet reported Hoffmann-La Roche 243 participants Est. completion 2021-05-31 30 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT02730546

    Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

    Not yet reported, Not yet reported Mayo Clinic 31 participants Est. completion 2023-10-31 2 sites Stand-alone
    Other conditions: Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage IIA Gastric Cancer AJCC v7, Stage IIB Gastric Cancer AJCC v7, Stage IIIA Gastric Cancer AJCC v7, Stage IIIB Gastric Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT02779283

    Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

    Not yet reported OHSU Knight Cancer Institute 7 participants Est. completion 2018-09-20 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02799472

    Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis

    Not yet reported GlaxoSmithKline 39 participants Est. completion 2017-10-30 16 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT02836977

    Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 400 participants Est. completion 2024-02-29 1 site Stand-alone
    Other conditions: Stage III Colon Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02843191

    Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

    Not yet reported Kyung Hee University Hospital at Gangdong 358 participants Est. completion 2026-06-30 14 sites Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02856867

    Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC
    Other conditions: Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemotherapy for Metastatic Esophagogastric Cancer
    View official trial listing →
  • Withdrawn NCT NCT02866448

    Impact of isoQUercetin and Aspirin on Platelet Function

    Not yet reported University of Reading Est. completion 2016-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02889081

    Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)

    Children's Hospital of Fudan University 487 participants Est. completion 2018-04-30 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Active, not recruiting NCT NCT02912559

    Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

    Not yet reported National Cancer Institute (NCI) 712 participants Est. completion 2026-12-18 1049 sites Stand-alone
    Other conditions: Colon Adenocarcinoma, DNA Repair Disorder, Lynch Syndrome, Stage III Colon Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT02928224

    Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

    Not yet reported Pfizer 702 participants Est. completion 2022-11-10 418 sites
    Other conditions: BRAF V600E-mutant Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02935764

    FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients

    Not yet reported Fudan University 164 participants Stand-alone
    Other conditions: Colorectal Carcinoma
    View official trial listing →
  • Completed NCT NCT02953522

    Polymorphism C677T MTHFR and Effects of Folate Intake

    Not yet reported Federal University of Paraíba 48 participants Est. completion 2016-09
    Other conditions: Overweight and Obesity
    View official trial listing →
  • Status unknown NCT NCT02959541

    PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer

    Not yet reported Vastra Gotaland Region 48 participants Est. completion 2022-12-31 1 site
    Other conditions: Colon Cancer, Chemotherapy
    View official trial listing →
  • Completed NCT NCT02969681

    Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer

    Not yet reported Sun Yat-sen University 442 participants Est. completion 2020-12-30 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Terminated NCT NCT02978222

    Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

    Not yet reported Marker Therapeutics, Inc. 120 participants Est. completion 2020-01-15 18 sites
    Other conditions: Platinum Sensitive Ovarian Cancer, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT02980510

    Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

    Not yet reported UNICANCER 219 participants Est. completion 2026-01 6 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03012100

    Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

    Not yet reported Academic and Community Cancer Research United 280 participants Est. completion 2026-07-31 12 sites
    Other conditions: Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma, Unilateral Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT03032549

    Safety of a Ready to Drink Supplement

    Not yet reported Texas A&M University 28 participants Est. completion 2016-09-01
    Other conditions: Dietary Supplements
    View official trial listing →
  • Status unknown NCT NCT03045770

    mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

    Not yet reported Fujian Cancer Hospital 150 participants Est. completion 2019-12-30 1 site
    Other conditions: Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT03084809

    Chemotherapy Combined With CIK Treating Colon Cancer

    Not yet reported China Meitan General Hospital 46 participants Est. completion 2014-09-15 Stand-alone
    Other conditions: Colorectal Cancer, Cytokine-induced Killer Cells, Postoperative Complications, Survival
    View official trial listing →
  • Completed NCT NCT03085992

    Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

    Not yet reported Azienda Ospedaliero, Universitaria Pisana 49 participants Est. completion 2018-03-12 4 sites Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT03089671

    Ureteric Visualization: Vitamin B Vs 5% Dextrose in Water

    Not yet reported Mount Sinai Hospital, Canada 238 participants Est. completion 2021-07-21 2 sites
    Other conditions: Pelvic Floor Disorders, Ureter; Kink
    View official trial listing →
  • Completed NCT NCT03146273

    Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)

    Not yet reported Galilee CBR 20 participants Est. completion 2017-07-01 1 site
    Other conditions: Vitamin Deficiency
    View official trial listing →
  • Completed NCT NCT03164382

    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

    Not yet reported Sun Yat-sen University 262 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Liver Cancer, Hepatic Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169738

    QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT03176030

    Fortified Foods in Older Inpatients

    University Hospital Southampton NHS Foundation Trust Est. completion 2018-03-31 1 site
    Other conditions: Malnutrition, Dementia, Aging, Frail Elderly Syndrome
    View official trial listing →
  • Completed NCT NCT03180307

    OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

    Not yet reported On Target Laboratories, LLC 140 participants Est. completion 2020-10-16 11 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT03186326

    Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer

    Not yet reported Federation Francophone de Cancerologie Digestive 132 participants Est. completion 2025-03-01 120 sites
    Other conditions: Metastatic Colorectal Cancer, MSI
    View official trial listing →
  • Status unknown NCT NCT03192644

    The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

    Not yet reported Sun Yat-sen University 162 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT03203525

    Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

    Not yet reported M.D. Anderson Cancer Center 38 participants Est. completion 2026-07-22 1 site Stand-alone
    Other conditions: Advanced Malignant Neoplasm, Colorectal Carcinoma Metastatic in the Liver, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT03206151

    CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer

    Not yet reported Taizhou Mabtech Pharmaceutical Co.,Ltd 520 participants Est. completion 2022-05-06 2 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03234452

    Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.

    Not yet reported Montefarmaco OTC SpA 50 participants Est. completion 2017-04-18 1 site
    Other conditions: Disbiosis, Abdominal Pain, Constipation, Diarrhea, Stress
    View official trial listing →
  • Completed NCT NCT03250832

    Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

    Not yet reported Tesaro, Inc. 111 participants Est. completion 2023-02-13 12 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03259399

    A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.

    Cui Yimin 2200 participants Est. completion 2020-06 1 site
    Cardiovascular disease Other conditions: Enalapril Adverse Reaction, Pharmacogenomics
    View official trial listing →
  • Completed NCT NCT03272022

    Micronutrient Status During Pregnancy

    Haukeland University Hospital 272 participants Est. completion 2016-02-08
    Other conditions: Deficiency Vitamins
    View official trial listing →
  • Completed NCT NCT03279237

    A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: GastroEsophageal Cancer
    View official trial listing →
  • Terminated NCT NCT03311750

    Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

    Not yet reported Hellenic Cooperative Oncology Group 23 participants Est. completion 2021-05-20 8 sites Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT03368859

    A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

    Not yet reported AbbVie 70 participants Est. completion 2019-12-18 65 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT03371667

    To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

    Not yet reported Assistance Publique - Hôpitaux de Paris 104 participants Est. completion 2025-01-24 1 site Stand-alone
    Other conditions: Allogeneic Disease, GVH - Graft Versus Host Reaction, GVHD, Acute, Stem Cell Transplant Complications
    View official trial listing →
  • Withdrawn NCT NCT03374852

    CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2020-10 Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03377842

    Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

    Not yet reported Sichuan Provincial People's Hospital 100 participants Est. completion 2020-09-01
    Other conditions: Colorectal Cancer, Neoadjuvant Therapy
    View official trial listing →
  • Status unknown NCT NCT03421483

    Assessing Colonic Folate Absorption & Metabolism

    Not yet reported The Hospital for Sick Children 24 participants Est. completion 2023-10-15 1 site
    Other conditions: Folate
    View official trial listing →
  • Terminated NCT NCT03426371

    Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

    Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 52 participants Est. completion 2021-11-27 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03472508

    H-Type Hypertension Precision Medicine Trial

    Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 3600 participants Est. completion 2019-06-30 5 sites
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT03483038

    A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

    Not yet reported University of Florida 45 participants Est. completion 2026-12 4 sites Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03504098

    Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients

    National Taiwan University Hospital 300 participants Est. completion 2020-07-31 1 site
    Other conditions: Lung Cancer, Nonsmall Cell
    View official trial listing →
  • Active, not recruiting NCT NCT03504397

    A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

    Not yet reported Astellas Pharma Global Development, Inc. 565 participants Est. completion 2026-09-30 220 sites Stand-alone
    Other conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT03536182

    Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2023-07-01 2 sites
    Other conditions: Locally Advanced Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03544671

    Effect of Vitamin D3 Supplementation in Children From 12 to 30 Months of Age.

    Not yet reported Instituto Nacional de Salud Publica, Mexico 220 participants Est. completion 2017-12-21 1 site
    Other conditions: Vitamin D Deficiency, 25-Hydroxyvitamin D3 Deficiency, Selective
    View official trial listing →
  • Withdrawn NCT NCT03554109

    QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine

    Not yet reported ImmunityBio, Inc. Est. completion 2022-02-09 1 site Stand-alone
    Other conditions: Triple Negative Breast Cancer (TNBC)
    View official trial listing →
  • Withdrawn NCT NCT03563170

    QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2019-08-23 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent
    View official trial listing →
  • Status unknown NCT NCT03567629

    Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

    Not yet reported Peking University 130 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: mCRC
    View official trial listing →
  • Status unknown NCT NCT03569995

    [CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

    Not yet reported Won Seog Kim 35 participants Est. completion 2025-06 1 site Stand-alone
    Other conditions: Primary CNS Lymphoma
    View official trial listing →
  • Completed NCT NCT03584711

    FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

    Not yet reported Federation Francophone de Cancerologie Digestive 118 participants Est. completion 2025-03-30 124 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03603834

    Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

    Not yet reported Khon Kaen University 25 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT03611556

    MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

    Not yet reported, Not yet reported MedImmune LLC 213 participants Est. completion 2022-07-22 27 sites Stand-alone
    Other conditions: Carcinoma, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03618758

    Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

    Not yet reported, Not yet reported Seoul National University Bundang Hospital 35 participants Est. completion 2023-12-02 1 site Stand-alone
    Other conditions: Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel, mFOLFOX6
    View official trial listing →
  • Completed NCT NCT03635957

    Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

    Not yet reported Amgen 14 participants Est. completion 2020-10-26 6 sites
    Other conditions: Gout
    View official trial listing →
  • Completed NCT NCT03665441

    Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

    Not yet reported ERYtech Pharma 512 participants Est. completion 2022-01-18 16 sites Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT03678428

    FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

    Not yet reported Sun Yat-sen University 92 participants Est. completion 2022-12-31 1 site
    Other conditions: Metastatic Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Completed NCT NCT03707535

    To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis

    Not yet reported Celltrion 270 participants Est. completion 2021-03-05 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Suspended NCT NCT03743428

    Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)

    Not yet reported Shenzhen People's Hospital 40 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT03748186

    Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

    Not yet reported Sutro Biopharma, Inc. 136 participants Est. completion 2024-06-04 27 sites
    Other conditions: Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Endometrial Cancer, Endometrioid Adenocarcinoma, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03751176

    Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

    Not yet reported Grupo Espanol Multidisciplinario del Cancer Digestivo 31 participants Est. completion 2022-11-30 18 sites Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT03771846

    HAIC Versus Systemic Chemotherapy for Unresectable ICC

    Not yet reported Shi Ming 188 participants Est. completion 2022-08-01 2 sites Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT03775343

    Early Postoperative Cognitive Impairment in Elderly Patients Following Ocular Surgery

    Medical University of Vienna 75 participants Est. completion 2023-08-30 1 site
    Other conditions: Cognitive Decline
    View official trial listing →
  • Completed NCT NCT03778593

    FOLFIRINOX for 2nd-line Treatment of BTC

    Not yet reported Dong-A University Hospital 34 participants Est. completion 2021-01-14 1 site Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT03837977

    Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma

    Not yet reported The Christie NHS Foundation Trust 58 participants Est. completion 2024-11-26 4 sites
    Other conditions: Oncology, Neuroendocrine Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03860012

    Folic Acid in Pediatric Inflammatory Bowel Disease

    Not yet reported Le Bonheur Children's Hospital 100 participants Est. completion 2020-05-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT03880877

    Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal Cancer

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 153 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03892395

    An Intervention Study to Investigate the Effect of B-vitamin Supplementation for 2-years on Bone Health

    Not yet reported University College Dublin 240 participants Est. completion 2022-05-31 1 site
    Other conditions: Bone Health
    View official trial listing →
  • Completed NCT NCT03903952

    Can B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?

    Not yet reported Sanliurfa Mehmet Akif Inan Education and Research Hospital 200 participants Est. completion 2015-05-30
    Other conditions: ASC-US, Human Papilloma Virus
    View official trial listing →
  • Completed NCT NCT03950674

    Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study

    Not yet reported Merck Sharp & Dohme LLC 40 participants Est. completion 2023-06-22 10 sites
    Other conditions: Non-Small-Cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT03959241

    TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

    Not yet reported Medical College of Wisconsin 431 participants Est. completion 2022-09-19 39 sites
    Other conditions: Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia, Lymphoma
    View official trial listing →
  • Completed NCT NCT03981029

    FACT Biomarker Subgroup Analysis

    Ottawa Hospital Research Institute 51 participants Est. completion 2016-09 4 sites
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Withdrawn NCT NCT03982121

    Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris Est. completion 2020-02-12 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03983057

    Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

    Not yet reported Zhejiang University 392 participants Est. completion 2025-11-25 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT04085354

    Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation

    Not yet reported Sohag University 120 participants Est. completion 2019-08-29 1 site
    Other conditions: Premature Ejaculation
    View official trial listing →
  • Status unknown NCT NCT04097444

    CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

    Not yet reported Chugai Pharmaceutical 112 participants Est. completion 2022-08-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04130854

    INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2026-01-30 4 sites Stand-alone
    Other conditions: Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT04166370

    Bangladesh MSNP: Social Protection Mixed Methods Study

    Not yet reported FHI 360 Est. completion 2020-06-28 1 site
    Other conditions: Stunting, Undernutrition
    View official trial listing →
  • Status unknown NCT NCT04170530

    Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

    Not yet reported First Affiliated Hospital of Zhejiang University 51 participants Est. completion 2022-01-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Completed NCT NCT04185597

    Bangladesh MSNP: Agricultural/Livelihood Mixed Methods Study

    Not yet reported FHI 360 4067 participants Est. completion 2020-06-28 1 site
    Other conditions: Stunting, Undernutrition
    View official trial listing →
  • Active, not recruiting NCT NCT04185883

    Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

    Not yet reported Amgen 610 participants Est. completion 2027-12-05 90 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
    View official trial listing →
  • Status unknown NCT NCT04204044

    Comparison of Myoinositol and Metformin in PCO

    Not yet reported Rashid Latif Medical College 126 participants Est. completion 2021-07-25 1 site
    Other conditions: PCOS
    View official trial listing →
  • Withdrawn NCT NCT04220892

    Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

    Not yet reported Jose Carrillo Est. completion 2020-07-08 1 site
    Other conditions: High Grade Glioma
    View official trial listing →
  • Completed NCT NCT04224402

    Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

    Not yet reported Yuhong Li 80 participants Est. completion 2022-12-31 1 site
    Other conditions: Pancreatic Cancer Resectable
    View official trial listing →
  • Completed NCT NCT04228263

    Hydroxychloroquine and Unexplained Recurrent Miscarriage

    Not yet reported Assiut University 156 participants Est. completion 2023-07-08 1 site
    Other conditions: Unexplained Recurrent Miscarriage
    View official trial listing →
  • Completed NCT NCT04229004

    A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Not yet reported Pancreatic Cancer Action Network 502 participants Est. completion 2025-02-05 25 sites
    Other conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04230187

    Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer

    Not yet reported Yanhong Deng 528 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04250428

    Strategies to Increase Antenatal Iron and Folic Acid Supplementation and Malaria Prophylaxis

    Not yet reported Centre Suisse de Recherches Scientifiques en Cote d'Ivoire 720 participants Est. completion 2021-12
    Other conditions: Antenatal Care
    View official trial listing →
  • Status unknown NCT NCT04252456

    Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status

    Not yet reported Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 150 participants Est. completion 2021-02 16 sites
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04283955

    A Retrospective Cohort Study: The Influence of MTHFR C677T and A1298C on the High-dose Methotrexate-Related Toxicities in Pediatric Patients With Non-Hodgkin Lymphoma

    Sun Yat-sen University 93 participants Est. completion 2019-03-01 1 site
    Other conditions: Pediatric NHL
    View official trial listing →
  • Completed NCT NCT04355949

    Assessment of Serum Levels of Vitamin D, Vitamin B12 and Folic Acid Among Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Treatment.

    Not yet reported Sohag University 60 participants Est. completion 2020-06-30 1 site
    Other conditions: Vitamin D, Vitamin B12 and Folic Acid Among Patients With Premature Ejaculation
    View official trial listing →
  • Status unknown NCT NCT04393584

    FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported, Not yet reported Blokhin's Russian Cancer Research Center 538 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Stomach Neoplasms, Gastrointestinal Neoplasms, Docetaxel, Oxaliplatin, Fluoruracil, Irinotecan Hydrochloride
    View official trial listing →
  • Status unknown NCT NCT04396457

    Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

    Not yet reported National Hospital Organization Nagoya Medical Center 50 participants Est. completion 2024-11 1 site
    Other conditions: Non-squamous Non-small-cell Lung Cancer, Cancer, Lung
    View official trial listing →
  • Status unknown NCT NCT04416854

    The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

    Not yet reported Fudan University 627 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Metastatic Colon Cancer, Surgery
    View official trial listing →
  • Withdrawn NCT NCT04418895

    Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2025-05 1 site
    Other conditions: Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04423965

    A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

    Not yet reported First Affiliated Hospital of Zhejiang University 220 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Completed NCT NCT04469556

    Pancreatic Adenocarcinoma Signature Stratification for Treatment

    Not yet reported University Health Network, Toronto 150 participants Est. completion 2025-03-05 6 sites
    Other conditions: Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Advanced Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04488172

    Exploring the Effects of Genetic Variants and Inflammation on Vitamins Supplementation Treatment Outcomes in Epilepsy

    Not yet reported National Cheng-Kung University Hospital 200 participants Est. completion 2021-07 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT04510064

    Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial

    Not yet reported Fudan University 40 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma, Gastric Cancer Adenocarcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT04513951

    AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

    Not yet reported Gruppo Oncologico del Nord-Ovest 62 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT04554836

    MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

    Not yet reported TheraOp 6 participants Est. completion 2024-06-11 4 sites Stand-alone
    Other conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
    View official trial listing →
  • Active, not recruiting NCT NCT04579848

    Methotrexate in Erosive Inflammatory Hand Osteoarthritis

    Not yet reported Diakonhjemmet Hospital 163 participants Est. completion 2026-12 1 site
    Osteoarthritis
    View official trial listing →
  • Terminated NCT NCT04583488

    Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

    Not yet reported Johns Hopkins University 2 participants Est. completion 2024-08-06 1 site
    Other conditions: Peritoneal Carcinomatosis
    View official trial listing →
  • Active, not recruiting NCT NCT04587128

    Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

    Not yet reported University of Wisconsin, Madison 34 participants Est. completion 2029-10 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04592913

    Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

    Not yet reported AstraZeneca 957 participants Est. completion 2027-09-27 156 sites Stand-alone
    Other conditions: Gastrointestinal Neoplasms, Esophagogastric Junction
    View official trial listing →
  • Status unknown NCT NCT04611724

    A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

    Not yet reported Asan Medical Center 35 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Urachal Cancer
    View official trial listing →
  • Status unknown NCT NCT04631536

    Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC

    Not yet reported Lebanese American University Medical Center 42 participants Est. completion 2022-07-01 1 site
    Other conditions: Covid19
    View official trial listing →
  • Withdrawn NCT NCT04682249

    Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

    Not yet reported Sun Yat-sen University Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: ICC
    View official trial listing →
  • Completed NCT NCT04723134

    Evaluation of a Folic Acid Wound Treatment (FAWT) for Chronic, Early-Stage Diabetic Foot Ulcer (DFU) Healing

    Not yet reported Joseph Boykin, MD 15 participants Est. completion 2024-09-24 1 site
    Other conditions: Diabetic Foot Ulcer
    View official trial listing →
  • Completed NCT NCT04751669

    Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial

    Not yet reported Fundació Institut Germans Trias i Pujol 252 participants Est. completion 2023-10-26 1 site
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04756713

    Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia

    Not yet reported Brigham and Women's Hospital 150 participants Est. completion 2025-12-31 7 sites
    Other conditions: Gestational Trophoblastic Neoplasia, Molar Pregnancy, Gestational Trophoblastic Tumor, Non-Metastatic
    View official trial listing →
  • Completed NCT NCT04761614

    Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported Ning Jin 13 participants Est. completion 2023-05-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Active, not recruiting NCT NCT04793932

    Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

    Not yet reported Associazione Italiana per lo Studio del Pancreas 261 participants Est. completion 2026-01-31 22 sites
    Other conditions: Pancreas Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04810585

    Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

    Not yet reported Yonsei University 153 participants Est. completion 2025-10 1 site Stand-alone
    Other conditions: Recurrent or Metastatic Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT04881851

    Effects of Inositol Alone or Associated With Alpha-lipoic Acid in Polycystic Ovary Syndrome Treatment

    Not yet reported Universita di Verona 76 participants Est. completion 2025-03-31 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT04884347

    Evaluation of the Efficacy of a Food Supplement in Reducing Hair Loss in Male Subjects

    Not yet reported Laboratoires Pharmaceutiques Trenker 100 participants Est. completion 2021-02-04 1 site
    Other conditions: Hair Loss
    View official trial listing →
  • Status unknown NCT NCT04913662

    Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

    Not yet reported Seoul National University Bundang Hospital 18 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Stomach Neoplasm, Peritoneal Metastases
    View official trial listing →
  • Status unknown NCT NCT04989049

    Therapeutic Effect of Folic Acid in Healing of Oral Ulcers

    Not yet reported Dow University of Health Sciences 75 participants Est. completion 2022-12
    Other conditions: Oral Ulcer
    View official trial listing →
  • Status unknown NCT NCT04994236

    Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

    Not yet reported Hui-Chuan Sun 49 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05012254

    Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

    Not yet reported Fundación GECP 71 participants Est. completion 2027-12-15 18 sites
    Other conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer
    View official trial listing →
  • Completed NCT NCT05013164

    Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder

    Not yet reported Nishtar Medical University 44 participants Est. completion 2021-03-30 1 site Stand-alone
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT05020847

    Effectiveness of Alternative Diets During the Stabilization Phase on Children With Complicated SAM

    Not yet reported University Ghent 297 participants Est. completion 2023-08-31 1 site
    Other conditions: Severe Acute Malnutrition, Kwashiorkor, Nutritional Edema, Marasmus
    View official trial listing →
  • Status unknown NCT NCT05022030

    First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

    Not yet reported West China Hospital 150 participants Est. completion 2026-06-01 1 site
    Other conditions: Colo-rectal Cancer, Capecitabine, Cetuximab
    View official trial listing →
  • Status unknown NCT NCT05029973

    HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2023-11-10 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05041257

    Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

    Not yet reported AbbVie 79 participants Est. completion 2024-12-12 35 sites
    Other conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    View official trial listing →
  • Completed NCT NCT05062044

    A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy

    Bayer 1500 participants Est. completion 2025-07-24 3 sites
    Other conditions: Prevention of Vitamin Deficiency During and/or Before Pregnancy
    View official trial listing →
  • Status unknown NCT NCT05074966

    The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

    Not yet reported Chinese Academy of Medical Sciences 314 participants Est. completion 2025-06-24 1 site
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05111860

    Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy

    Not yet reported, Not yet reported Shanghai Minimally Invasive Surgery Center 20 participants Est. completion 2025-08-01 1 site Stand-alone
    Other conditions: Neoadjuvant Treatment, Rectal Cancer, Bevacizumab, Radiotherapy
    View official trial listing →
  • Completed NCT NCT05116891

    A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

    Not yet reported, Not yet reported Cantargia AB 40 participants Est. completion 2023-06-23 6 sites
    Other conditions: Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer, Biliary Tract Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05141721

    A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Seattle Project Corporation 700 participants Est. completion 2027-03 43 sites Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT05166772

    Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2024-12 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05166980

    Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India

    Not yet reported University of California, San Francisco 1389 participants Est. completion 2024-05-02 1 site
    Other conditions: Nutrient Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT05169021

    Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD

    Not yet reported Beijing Tiantan Hospital 15000 participants Est. completion 2028-12-31 1 site
    Cardiovascular disease Other conditions: Cerebral Small Vessel Diseases
    View official trial listing →
  • Terminated NCT NCT05171166

    Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

    Not yet reported, Not yet reported Peking University 18 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05178407

    Effect of Household Use of Multiple Micronutrient-fortified Bouillon on Micronutrient Status Among Women and Children in Two Districts in the Northern Region of Ghana

    Not yet reported University of California, Davis 2372 participants Est. completion 2024-06-12 1 site
    Other conditions: Vitamin A Deficiency, Iron-deficiency, Folate Deficiency, Vitamin B 12 Deficiency, Zinc Deficiency, Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT05198609

    Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

    Not yet reported Sun Yat-sen University 214 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05268510

    Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 31 participants Est. completion 2025-01-09 1 site Stand-alone
    Other conditions: Esophagogastric Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05290116

    HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

    Not yet reported Yunfei Yuan 17 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT05380934

    A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 63 participants Est. completion 2023-05-20 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05389813

    Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia

    Not yet reported, Not yet reported An-Najah National University 150 participants Est. completion 2024-05-01 1 site
    Other conditions: Anesthesia
    View official trial listing →
  • Status unknown NCT NCT05398224

    R-MTX-zanbrutinib in Secondary CNS Lymphoma

    Not yet reported Peking University 45 participants Est. completion 2024-05-26 1 site Stand-alone
    Other conditions: Secondary Central Nervous System Lymphoma
    View official trial listing →
  • Terminated NCT NCT05417386

    FOLFIRINOX + NIS793 in Pancreatic Cancer

    Not yet reported Colin D. Weekes, M.D., PhD 4 participants Est. completion 2023-07-10 1 site Stand-alone
    Other conditions: Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05493332

    HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 93 participants Est. completion 2024-09 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05494320

    the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

    Ain Shams University 120 participants Est. completion 2022-12-31 1 site
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Status unknown NCT NCT05498597

    AMT-151 in Patients With Selected Advanced Solid Tumours

    Not yet reported Multitude Therapeutics Inc. 30 participants Est. completion 2024-10-30 9 sites
    Other conditions: Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovarian Epithelial Cancer, Ovarian Endometrioid Adenocarcinoma, Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Lung Adenocarcinoma, Triple Negative Breast Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Pleural Mesothelioma, Ovarian Clear Cell Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Mucinous Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05546853

    Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

    Not yet reported University Hospital, Grenoble 43 participants Est. completion 2025-06-16 9 sites
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05568095

    A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

    Not yet reported Arcus Biosciences, Inc. 1040 participants Est. completion 2026-08-28 168 sites Stand-alone
    Other conditions: Advanced Upper Gastrointestinal Tract Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05580887

    Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

    Moscow Clinical Scientific Center 35 participants Est. completion 2025-08 1 site
    Other conditions: Breast Cancer, Pancreas Cancer
    View official trial listing →
  • Completed NCT NCT05615012

    A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

    Not yet reported Bristol-Myers Squibb 76 participants Est. completion 2023-12-13 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05616000

    Comparison of Acetyl- L- Carnitine& Folic Acid Versus Coenzyme Q10& Folic Acid on Semen& Hormonal Parameters& Semen Oxidative Status in Patients of Primary Infertility. A Double Blind Randomized Clinical Trial

    Not yet reported Khyber Medical University Peshawar 86 participants Est. completion 2022-11-29 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT05633680

    Circulating Tumor Cells Screen for Breast Cancer

    Handan First Hospital 200 participants Est. completion 2023-06-20 1 site
    Other conditions: Breast Neoplasm, Neoplastic Cells, Circulating
    View official trial listing →
  • Terminated NCT NCT05699473

    Bioavailability Study of Folate in Healthy Subjects

    Not yet reported Lesaffre International 12 participants Est. completion 2023-05-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05710055

    The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics

    Not yet reported Shenzhen Precision Health Food Technology Co. Ltd., 200 participants Est. completion 2023-04-30 2 sites
    Other conditions: Overweight
    View official trial listing →
  • Active, not recruiting NCT NCT05715931

    Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported Yu jiren 30 participants Est. completion 2028-10-01 8 sites Stand-alone
    Other conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
    View official trial listing →
  • Completed NCT NCT05752955

    SMART Health Pregnancy 2 - Intervention to Reduce Anaemia and Cardiometabolic Risk During Pregnancy and in the First Year Following Birth

    Not yet reported The George Institute 3446 participants Est. completion 2025-05-01 1 site
    Type 2 diabetes Other conditions: Anemia of Pregnancy, Gestational Diabetes, Gestational Hypertension, Pre-Eclampsia, Anemia, Hypertension
    View official trial listing →
  • Status unknown NCT NCT05774964

    Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

    Not yet reported Liaoning Cancer Hospital & Institute 100 participants Est. completion 2025-03-15 1 site
    Other conditions: For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
    View official trial listing →
  • Completed NCT NCT05807711

    Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated With Elevated Serum Homocysteine in Hemodialysis Patients.

    Not yet reported Alexandria University 51 participants Est. completion 2024-05-01 1 site
    Other conditions: End Stage Renal Disease, Hypertension, Renal
    View official trial listing →
  • Status unknown NCT NCT05864755

    HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Unrescetable Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05872841

    H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 38 participants Est. completion 2025-06-30 Stand-alone
    Other conditions: Primary Hepatocellular Carcinoma, Portal Vein Thrombosis
    View official trial listing →
  • Active, not recruiting NCT NCT05920798

    Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

    Not yet reported, Not yet reported Mayo Clinic 38 participants Est. completion 2030-10-28 3 sites
    Obstructive sleep apnea Other conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Clear Cell Adenocarcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05948072

    Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

    Not yet reported Fudan University 250 participants Est. completion 2026-07-15 1 site Stand-alone
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT05986227

    The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):

    Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 126 participants Est. completion 2026-07-01 Stand-alone
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT06009198

    Nutritional, and WASH Related Education Intervention to Address Malnutrition of Early Adolescents in Pakistan

    Not yet reported Aga Khan University 635 participants Est. completion 2022-05-30 1 site
    Other conditions: Malnutrition
    View official trial listing →
  • Completed NCT NCT06042738

    Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile Men

    Not yet reported Ondokuz Mayıs University 48 participants Est. completion 2021-11-01 1 site
    Other conditions: Male Infertility
    View official trial listing →
  • Completed NCT NCT06045377

    Effect of Armolipid on Lipid Profile in Children With Hypercholesterolemia

    Not yet reported Athens General Children's Hospital "Pan. & Aglaia Kyriakou" 90 participants Est. completion 2022-09-05 1 site
    Other conditions: Dyslipidemias, Children, Only
    View official trial listing →
  • Completed NCT NCT06100146

    Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls

    Not yet reported University Ghent 472 participants Est. completion 2024-08-31 2 sites
    Other conditions: Folate Deficiency, Vitamin B 12 Deficiency, Anemia, Megaloblastic, Cognitive Development, Depressive Symptoms
    View official trial listing →
  • Status unknown NCT NCT06123455

    Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

    Not yet reported Tang-Du Hospital 60 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT06125860

    BEP Targeting Strategies in Ethiopia

    Not yet reported Harvard School of Public Health (HSPH) 7851 participants Est. completion 2026-08-07 1 site
    Other conditions: Small for Gestational Age at Delivery, Gestational Weight Gain, Stillbirth, Preterm Birth, Birth Weight, Maternal Anemia in Pregnancy, Before Birth, Neonatal Death, Perinatal Death
    View official trial listing →
  • Completed NCT NCT06139211

    A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Shanghai Junshi Bioscience Co., Ltd. 66 participants Est. completion 2026-05-28 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Withdrawn NCT NCT06169826

    Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease

    Not yet reported Wake Forest University Health Sciences Est. completion 2026-04 1 site
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT06199297

    Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

    Sun Yat-sen University 188 participants Est. completion 2023-07-25 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06235294

    Effects of Resveratrol Supplementation on Oocyte Quality

    Not yet reported Unidade Local de Saúde de Coimbra, EPE 88 participants Est. completion 2025-12
    Other conditions: Aging, Infertility
    View official trial listing →
  • Status unknown NCT NCT06269445

    The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

    Not yet reported Sir Run Run Shaw Hospital 20 participants Est. completion 2026-02-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06327646

    Maternal Adherence to MMS in Nepal

    Not yet reported Helen Keller International 2640 participants Est. completion 2025-09 119 sites
    Other conditions: Supplementation
    View official trial listing →
  • Status unknown NCT NCT06329947

    A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

    Not yet reported Rui-hua Xu, MD, PhD 37 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06375317

    HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

    Not yet reported Yehua Shen 42 participants Est. completion 2026-10-30 Stand-alone
    Other conditions: HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT06376253

    A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

    Not yet reported Novartis Pharmaceuticals 4 participants Est. completion 2025-07-10 1 site
    Other conditions: Ovarian Cancer, Lung Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06401447

    TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

    Not yet reported Fudan University 50 participants Est. completion 2027-07-10 1 site Stand-alone
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06405204

    of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

    Not yet reported Beni-Suef University 200 participants Est. completion 2024-12-30 1 site
    Other conditions: IVF
    View official trial listing →
  • Status unknown NCT NCT06463444

    Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

    Not yet reported Chen Xiaoping 30 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: HCC, Precision Therapy
    View official trial listing →
  • Completed NCT NCT06476366

    Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial

    Not yet reported Pak Emirates Military Hospital 50 participants Est. completion 2025-12-28 1 site
    Other conditions: Chronic Actinic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT06481696

    Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

    Not yet reported Andros Day Surgery Clinic 90 participants Est. completion 2025-12-31 1 site
    Other conditions: Unexplained Infertility
    View official trial listing →
  • Status unknown NCT NCT06512753

    The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference Trial

    Erasmus Medical Center 56 participants Est. completion 2026-07-01 1 site
    Other conditions: Lichen Planopilaris, Cicatricial Alopecia
    View official trial listing →
  • Completed NCT NCT06516094

    Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain

    Not yet reported Laboratorios Silanes S.A. de C.V. 192 participants Est. completion 2025-01-07 1 site
    Other conditions: Chronic Low-back Pain
    View official trial listing →
  • Not yet recruiting NCT NCT06641245

    PREconception Folic Acid Clinical Efficacy (PREFACE) Trial

    Not yet reported University of British Columbia 272 participants Est. completion 2030-01-31
    Other conditions: Folate, Folate Bioavailability, Clinical Trials, Pregnancy
    View official trial listing →
  • Active, not recruiting NCT NCT06875947

    EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

    Not yet reported Universitas Padjadjaran 59 participants Est. completion 2026-05-31 1 site
    Other conditions: Iron Deficiency Anemia of Pregnancy, Pregnancy Complications, Inflammation, Moringa Oleifera, Cytokines (IL-1, IL-6), Hepcidin
    View official trial listing →
  • Not yet recruiting NCT NCT06888037

    Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

    Not yet reported Ruijin Hospital 55 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy, Fruquintinib, PD-1
    View official trial listing →
  • Not yet recruiting NCT NCT06959693

    A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

    Not yet reported, Not yet reported Sun Yat-sen University 590 participants Est. completion 2030-06-30 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Not yet recruiting NCT NCT06965244

    Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

    Not yet reported Assistance Publique - Hôpitaux de Paris 122 participants Est. completion 2029-04-01
    Other conditions: Cutaneous Lupus Erythematosus (CLE)
    View official trial listing →
  • Active, not recruiting NCT NCT06967155

    A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

    Not yet reported Blokhin's Russian Cancer Research Center 23 participants Est. completion 2028-06-10 1 site Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Not yet recruiting NCT NCT06993025

    Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2027-04-25 2 sites Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT07029698

    A Study to See if a Combination of Vitamins That is Injected Into a Muscle is as Good and Safe as a Vitamin That is Taken by Mouth

    Not yet reported Medice Arzneimittel Pütter GmbH & Co KG 46 participants Est. completion 2025-10-07 2 sites
    Other conditions: Vitamin B12 Deficiency
    View official trial listing →
  • Not yet recruiting NCT NCT07074353

    Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

    Not yet reported Zhejiang Cancer Hospital 360 participants Est. completion 2030-07-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07118800

    Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

    Not yet reported UNICANCER 160 participants Est. completion 2032-01-15 Stand-alone
    Other conditions: Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07277842

    PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

    Not yet reported Sun Yat-sen University 382 participants Est. completion 2028-12-29 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Locally Advanced Low Rectal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT07292259

    Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia

    Not yet reported Pakistan Blood and Marrow Transplant (PBMT) Group 100 participants Est. completion 2025-12-30 9 sites
    Other conditions: Transfusion Dependent Beta Thalassemia
    View official trial listing →
  • Enrolling by invitation NCT NCT07334587

    Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

    Not yet reported Allama Iqbal Medical College 248 participants Est. completion 2026-02-28 1 site
    Other conditions: Metastatic Colorectal Carcinoma (mCRC)
    View official trial listing →
  • Completed NCT NCT07391163

    Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

    Not yet reported Tanta University 46 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT07487610

    Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older

    Sultan 1. Murat State Hospital 450 participants Est. completion 2026-06-30 1 site
    Other conditions: Neuropathic Pain, Old Age; Debility, Pain
    View official trial listing →
  • Not yet recruiting NCT NCT07515963

    FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

    Not yet reported Zhongnan Hospital 24 participants Est. completion 2028-02-01 1 site Stand-alone
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07618546

    A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

    Not yet reported Henan Cancer Hospital 208 participants Est. completion 2028-03-31 Stand-alone
    Other conditions: HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07621497

    FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

    Not yet reported Sun Yat-sen University 229 participants Est. completion 2030-06-01 1 site
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Not yet recruiting NCT NCT07665957

    MMS, IFA, and MMS+IFA Supplementation in Pregnant Women

    Not yet reported Sindh Institute of Child Health and Neonatology 402 participants Est. completion 2027-01-25
    Other conditions: Maternal Anemia, Micronutrient Deficiency, Pregnancy Outcomes, Maternal Nutrition
    View official trial listing →
  • Not yet recruiting NCT NCT07680569

    Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma

    Not yet reported, Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 40 participants Est. completion 2027-12 Stand-alone
    Other conditions: GC/GEJC
    View official trial listing →
  • Not yet recruiting NCT NCT07737600

    A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer

    Not yet reported, Not yet reported Lepu Biopharma Co., Ltd. 316 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07750041

    A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer

    Not yet reported, Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 260 participants Est. completion 2029-08-30 1 site Stand-alone
    Other conditions: Unresectable Advanced or Metastatic Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07765667

    NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 100 participants Est. completion 2029-09-01 1 site Stand-alone
    Other conditions: Rectal Adenocarcinoma, High-Risk Cancer, MSS
    View official trial listing →
  • Not yet recruiting NCT NCT07810114

    Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer

    Not yet reported Fudan University 52 participants Est. completion 2030-12-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07844057

    First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma

    Not yet reported Annika Kurreck 86 participants Est. completion 2034-04-01 16 sites
    Other conditions: Small-bowel Adenocarcinoma, Metastatic Disease, Chemotherapy Effect
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.